Kiniksa Pharmaceuticals International, plc (KNSA) is listed on NASDAQ in Pharmaceutical Stocks. It is $78.10, -2.13%, with a $6.0B market cap. RSI is 60.4, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 60.4 Near Overbought
Market Cap $6.0B
P/E Ratio 289.3x
Volume 309.6K
Fundamentals — 10-Q Q1 2026
Revenue $214.3M
Net Income $22.6M
EPS $0.27
Gross Margin 90.3%
Operating Margin 13.7%
Net Margin 10.5%
P/E Ratio 289.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Cole G Bradley | Insider | Sell | 3,673 | $81.43 | $299,092 | 2026 Jul 29 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 58,424 | $53.71 | $3.1M | 2026 May 1 |
| Patel Sanj K | CHAIRMAN & CEO | Sell | 48,565 | $54.02 | $2.6M | 2026 May 1 |
| Patel Sanj K | CHAIRMAN & CEO | Sell | 508,339 | $51.96 | $26.4M | 2026 Apr 30 |
| Quart Barry D | Insider | Sell | 13,099 | $50.10 | $656,260 | 2026 Apr 28 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Sell | 6,625 | $46.69 | $309,321 | 2026 Apr 9 |
| Moat Ross | CHIEF OPERATING OFFICER | Sell | 1,703 | $46.69 | $79,513 | 2026 Apr 9 |
| Patel Sanj K | CHAIRMAN & CEO | Sell | 7,278 | $50.01 | $363,973 | 2026 Apr 6 |
| Moat Ross | CHIEF OPERATING OFFICER | Sell | 2,367 | $48.58 | $114,989 | 2026 Apr 6 |
| Quart Barry D | Insider | Sell | 6,901 | $50.00 | $345,050 | 2026 Apr 6 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 40,000 | $44.82 | $1.8M | 2026 Mar 2 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $500,715 | 2025 Dec 15 |
| Quart Barry D | Director | Sell | 20,129 | $41.51 | $835,555 | 2025 Dec 15 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.8M | 2025 Dec 8 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $8,578 | 2025 Nov 26 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sell | 12,470 | $41.24 | $514,224 | 2025 Nov 17 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $814,706 | 2025 Nov 12 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Sell | 82,542 | $37.14 | $3.1M | 2025 Oct 31 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sell | 100 | $41.00 | $4,100 | 2025 Oct 28 |
| Patel Sanj K | CHAIRMAN & CEO | Sell | 257,969 | $38.86 | $10.0M | 2025 Oct 22 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $18.04 | 57.2 | -- |
Take KNSA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put KNSA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Kiniksa Pharmaceuticals International, plc next reports.
Set alerts on KNSA
Get notified when Kiniksa Pharmaceuticals International, plc hits your price targets or technical conditions are met.
Get Started Free